Deep Vein Thrombosis News and Research

RSS
Deep vein thrombosis, or DVT, is a blood clot that forms in a vein deep in the body. Most deep vein clots occur in the lower leg or thigh. If the vein swells, the condition is called thrombophlebitis. A deep vein thrombosis can break loose and cause a serious problem in the lung, called a pulmonary embolism, or a heart attack or stroke.
Study aims at best way to treat deep vein thrombosis

Study aims at best way to treat deep vein thrombosis

Anti-clotting treatment not needed for all kids who undergo spine operations

Anti-clotting treatment not needed for all kids who undergo spine operations

New technology removes blood clots

New technology removes blood clots

European Commission approves Boehringer Ingelheim's Pradaxa for prevention of DVT and PE

European Commission approves Boehringer Ingelheim's Pradaxa for prevention of DVT and PE

Pradaxa receives FDA approval for treatment and reduction of risk of recurrence of DVT and PE

Pradaxa receives FDA approval for treatment and reduction of risk of recurrence of DVT and PE

New approach can improve patient outcomes, reduce complications in complex spine surgeries

New approach can improve patient outcomes, reduce complications in complex spine surgeries

Bristol-Myers Squibb, Pfizer announce FDA approval of Eliquis for DVT prophylaxis

Bristol-Myers Squibb, Pfizer announce FDA approval of Eliquis for DVT prophylaxis

Study finds higher readmission rates for same-day total joint replacement surgery

Study finds higher readmission rates for same-day total joint replacement surgery

Statins combined with conventional blood clot prevention therapies, reduce VTE risk by 48%

Statins combined with conventional blood clot prevention therapies, reduce VTE risk by 48%

Long-term risks of deep vein thrombosis

Long-term risks of deep vein thrombosis

Mobile compression device just as effective as blood thinners in preventing DVT after joint surgery

Mobile compression device just as effective as blood thinners in preventing DVT after joint surgery

Women's blood clot risk remains elevated for at least 12 weeks after delivering a baby, says study

Women's blood clot risk remains elevated for at least 12 weeks after delivering a baby, says study

Research helps identify stroke patients at risk for mortality and treatments to reduce death rate

Research helps identify stroke patients at risk for mortality and treatments to reduce death rate

Use of standardized medical management protocol and surgery can improve life expectancy

Use of standardized medical management protocol and surgery can improve life expectancy

Bristol-Myers Squibb fourth quarter 2013 revenues increase 6% to $4.4 billion

Bristol-Myers Squibb fourth quarter 2013 revenues increase 6% to $4.4 billion

Daiichi Sankyo submits Marketing Authorization Application for edoxaban to EMA

Daiichi Sankyo submits Marketing Authorization Application for edoxaban to EMA

FDA approves Baxter's FEIBA for prophylactic treatment of hemophilia patients with inhibitors

FDA approves Baxter's FEIBA for prophylactic treatment of hemophilia patients with inhibitors

Celgene: FIRST trial meets primary endpoint in patients newly diagnosed with multiple myeloma

Celgene: FIRST trial meets primary endpoint in patients newly diagnosed with multiple myeloma

WHO releases new report on spinal cord injury

WHO releases new report on spinal cord injury

Researchers explore strategies that would optimize fresher blood for patients

Researchers explore strategies that would optimize fresher blood for patients